Buckingham Capital Management, Inc. Amgen Inc Transaction History

Buckingham Capital Management, Inc.

$863 Million
Q3 2024

A detailed history of Buckingham Capital Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Buckingham Capital Management, Inc. holds 750 shares of AMGN stock, worth $210,052. This represents 0.03% of its overall portfolio holdings.

Number of Shares

750

Previous 750 -0.0%

Holding current value

$210,052

Previous $234,000 2.99%

% of portfolio

0.03%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 10, 2024	SELL	$268.87 - $324.56 $55,924 - $67,508	-208 Reduced 21.71%	750 $213,000
Q4 2023 Feb 07, 2024	BUY	$255.7 - $288.46 $2,045 - $2,307	8 Added 0.84%	958 $275,000
Q2 2021 Jul 27, 2021	SELL	$233.58 - $259.14 $46,716 - $51,828	-200 Reduced 17.39%	950 $232,000
Q1 2021 May 04, 2021	SELL	$221.91 - $258.6 $3,328 - $3,879	-15 Reduced 1.29%	1,150 $286,000
Q4 2020 Feb 04, 2021	SELL	$216.38 - $257.67 $14,064 - $16,748	-65 Reduced 5.28%	1,165 $268,000
Q3 2020 Nov 02, 2020	BUY	$234.65 - $260.95 $15,252 - $16,961	65 Added 5.58%	1,230 $313,000
Q1 2020 May 06, 2020	SELL	$182.24 - $241.7 $2,733 - $3,625	-15 Reduced 1.27%	1,165 $236,000
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $1.55 Million - $1.86 Million	-8,895 Reduced 88.29%	1,180 $228,000
Q2 2019 Aug 09, 2019	SELL	$166.7 - $195.41 $690,971 - $809,974	-4,145 Reduced 29.15%	10,075 $1.86 Million
Q1 2019 May 07, 2019	SELL	$180.87 - $203.88 $589,817 - $664,852	-3,261 Reduced 18.65%	14,220 $2.7 Million
Q4 2018 Feb 04, 2019	SELL	$178.4 - $208.25 $172,691 - $201,586	-968 Reduced 5.25%	17,481 $3.4 Million
Q3 2018 Nov 20, 2018	SELL	$185.29 - $208.89 $82,824 - $93,373	-447 Reduced 2.37%	18,449 $3.82 Million
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $63,597 - $71,433	-383 Reduced 1.99%	18,896 $3.49 Million
Q1 2018 May 11, 2018	SELL	$169.43 - $198.0 $80,987 - $94,644	-478 Reduced 2.42%	19,279 $3.29 Million
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $126,592 - $141,442	-750 Reduced 3.66%	19,757 $3.44 Million
Q3 2017 Nov 07, 2017	SELL	$167.29 - $191.0 $140,690 - $160,631	-841 Reduced 3.94%	20,507 $3.82 Million
Q2 2017 Aug 10, 2017	BUY	N/A	21,348	21,348 $3.68 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Buckingham Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Buckingham Capital Management, Inc. with notifications on news.

Account

Buckingham Capital Management, Inc. Amgen Inc Transaction History